Gilead's AIDS Drug Wins FDA Approval

Biotech company Gilead Sciences (GILD Quote) said late Friday that U.S. drug regulators approved its new HIV drug, Viread.

When taken with other antiretroviral drugs, Viread is able to significantly reduce a patient's levels of HIV. Most significantly, Viread was tested on, and is successful in, patients who have failed to respond to other HIV drugs.

Viread is a taken as a once-a-day pill. Foster City, Calif.-based Gilead says the new drug will be on pharmacy shelves within days. ...